Ledigt jobb

Helse Sør-øst RHF

Postdoctoral researcher position available in immunology & cell therapy development for melanoma

Offentlig forvaltning

We are looking for a highly motivated postdoctoral researcher in a 100 % position, to join our team for 3 years at the Translational Research Unit (PIs: Dr. Sébastien Wälchli and Dr. Else Marit Inderberg), Section for Cellular therapy, Oslo University Hospital-Radium Hospital, Oslo, Norway.

The Section for Cellular Therapy counts 40 employees split in a clinical ward (GMP facility) and the Translational Research Unit (20 employees and students), which is developing pre-clinical solutions in cancer immunotherapy. Our unit has the capacity to run full pre-clinical validations of TCR and CAR molecules: Radium-1 TCR was also the first ever tested in an academic clinical trial in Scandinavia (Radium-1 TCR, NCT03431311; Maggadottir et al. 2024). Our discoveries have led to the establishment of two biotech companies and our unit is located at the Oslo Cancer Cluster Incubator (https://occincubator.com/), next to the Radium Hospital, which represents an excellent environment for innovative development. 

Oslo University Hospital is a workplace with great diversity. We believe this is crucial to solving our tasks in the best possible way. We want this diversity to be reflected among the applicants for our positions, and encourage all qualified candidates, regardless of background, to apply.

Kvalifikasjoner:

Only highly motivated candidates should apply for this position. He/she should be able to both work independently and be strong team player. He/she should fulfil the following criteria:

  • PhD or other corresponding education equivalent to a Norwegian doctoral degree.
  • We are seeking candidates with a strong background in T-cell immunology/immunotherapy.
  • All candidates should have documented previous experience with primary T cell culture, melanoma, and immune checkpoint molecules. The candidate should also have experience with genetic modification of primary T cells, preferably CRISPR-Cas9 knock-out and knock-in.
  • The candidate should possess strong experience in several of these technologies (to be documented via certificate or scientific publications): mastering advanced flow cytometry and  FACS-based sorting, cytokine measurements by ELISPOT and/or ELISA, human T-cell cloning, cytotoxicity assays, Western blot, and immunohistochemistry.
  • It will be considered as an advantage to have prior experience with in vivo experimental work, including intravenous and subcutaneous in injections. 
  • A good command of English and informatics tools are expected and ability to independently write scientific articles will be required.

Personlige egenskaper:

  • Application letter (1 page max).
  • CV (2 pages max, summarizing education, previous positions, list of publications).
  • Official copies of educational certificates (University level) with grades.
  • Names and contact details of min 1 reference.

The application must be submitted through Webcruiter, together with uploaded relevant diplomas and documents/certificates.

Vi tilbyr:

Do you want to know more about Oslo University Hospital?
Les om arbeidsplassen vår her: https://www.oslo-universitetssykehus.no/om-oss/jobb-og-utdanning/arbeidsplassen-var